K Number
K060811
Date Cleared
2006-05-25

(62 days)

Product Code
Regulation Number
868.5630
Reference & Predicate Devices
Predicate For
AI/MLSaMDIVD (In Vitro Diagnostic)TherapeuticDiagnosticis PCCP AuthorizedThirdpartyExpeditedreview
Intended Use

The Omron Compressor Nebulizer Systems include a compressor and nebulizer, Model NE-C28 uses a DC powered compressor and Model NE-C30 can operate with AC/DC power. The electrically powered compressor provides compressed air to the supplied pneumatic nebulizer to aerosolize drugs for inhalation by the patient.

The nebulizer is driven by the integral air compressor. The device may be used with pediatric and adult patients in the home, hospital, and sub-acute care settings.

Not intended for use with Pentamidine.

Device Description

The Oniron Compressor Systems, model NE-C28 and NE-C30, consist of a nebulizer and AC powered piston-type compressor that's generates compressed air. The Model NE-C30 also includes a rechargeable battery pack and can be connected to DC voltage.

Both units utilize the same handheld nebulizer, which is a venturi type which converts the liquid medication into a fine aerosol which is inhaled by the patient via a mouthpiece of mask. The nebulizers can be cleaned and reused.

AI/ML Overview

The provided document is a 510(k) premarket notification for Omron Compressor Systems, Models NE-C28 and NE-C30. This type of submission focuses on demonstrating substantial equivalence to a legally marketed predicate device rather than conducting new clinical studies or establishing detailed acceptance criteria based on performance studies.

Therefore, the document does not contain the information requested regarding acceptance criteria studies for a device with embedded AI or similar technologies that would require a detailed performance evaluation against a specific ground truth.

Specifically, the following information is not present in the document:

  1. A table of acceptance criteria and the reported device performance: The document lists device attributes (like drug delivery rate, reservoir size) and operating conditions, but these are specifications, not performance acceptance criteria against a clinical outcome or diagnostic accuracy.
  2. Sample size used for the test set and the data provenance: No test sets, clinical studies, or data provenance information is mentioned.
  3. Number of experts used to establish the ground truth for the test set and the qualifications of those experts: Ground truth establishment is irrelevant in this type of submission.
  4. Adjudication method for the test set: Not applicable.
  5. If a multi-reader multi-case (MRMC) comparative effectiveness study was done, and if so, what was the effect size of how much human readers improve with AI vs without AI assistance: This is a compressor nebulizer system, which does not involve human readers or AI assistance in the way, for example, an AI diagnostic tool would.
  6. If a standalone (i.e., algorithm only without human-in-the-loop performance) was done: Not applicable, as this is not an AI algorithm.
  7. The type of ground truth used (expert consensus, pathology, outcomes data, etc.): Not applicable.
  8. The sample size for the training set: Not applicable.
  9. How the ground truth for the training set was established: Not applicable.

The document primarily focuses on:

  • Device Description: What the device is and how it works.
  • Intended Use/Indications for Use: What the device is for and for whom.
  • Predicate Device Comparison: Demonstrating substantial equivalence to a previously cleared device (Omron NE-C09 - K914836) by comparing features and specifications.
  • Safety Standards: Listing compliance with relevant electrical safety and risk management standards (IEC 60601-1, IEC 60601-1-2, UL 60601-1, FCC Part 15, ISO 14971).

The core of a 510(k) submission for this type of device is to show that it is "as safe and effective as, or substantially equivalent to, a legally marketed device" and does not typically involve the kind of performance studies with acceptance criteria, ground truth, and expert evaluation that would be required for a novel diagnostic device or an AI-powered system.

{0}------------------------------------------------

MAY 2 5 2006

Image /page/0/Picture/1 description: The image shows the text "Kob0811" in a handwritten style. The text appears to be written with a thick marker or pen, giving it a bold and somewhat uneven appearance. The characters are spaced closely together, and the overall impression is that of a quick, informal note.

Premarket Notification 510(k) ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------ Omron

510(k) Summary

Non-Confidential Summary of Safety and Effectiveness Page 1 of 2 19-May-06

Omron Healthcare, Inc.Tel - 847-247-5713
1200 Lakeside Dr.Fax - 847-680-6269
Bannockburn, IL 60015
Official Contact:Donna Djinovich - Regulatory Affairs Manager
Proprietary or Trade Name:Omron Compressor Systems
Common/Usual Name:Nebulizer Compressor Systems
Classification Name:Nebulizer (Direct Patient Interface)
Device:Models NE-C28 and NE-C30
Predicate Devices:Omron - NE-C09 - K914836
Device Description:

The Oniron Compressor Systems, model NE-C28 and NE-C30, consist of a nebulizer and AC powered piston-type compressor that's generates compressed air. The Model NE-C30 also includes a rechargeable battery pack and can be connected to DC voltage.

Both units utilize the same handheld nebulizer, which is a venturi type which converts the liquid medication into a fine aerosol which is inhaled by the patient via a mouthpiece of mask. The nebulizers can be cleaned and reused.

Indications for Use:
Indicated Use --The Omron Compressor Nebulizer Systems include a compressorand nebulizer, Model NE-C28 uses a DC powered compressorand Model NE-C30 can operate with AC/DC power. Theelectrically powered compressor provides compressed air to thesupplied pneumatic nebulizer to aerosolize drugs for inhalationby the patient.
The nebulizer is driven by the integral air compressor. Thedevice may be used with pediatric and adult patients in the home,hospital, and sub-acute care settings.
Not intended for use with Pentamidine.
Patient Population --Pediatric and adult

{1}------------------------------------------------

Non-Confidential Summary of Safety and Effectiveness

Page 2 of 2 19-May-06

Environment of Use --Home, hospital, and sub-acute care settings.
Contraindications --None

Device Attributes:

FeaturesNE-C28NE-C30
Indications for useThe electrically powered compressor provides compressedair to the supplied pneumatic nebulizer to aerosolize drugsfor inhalation by the patient.The nebulizer is driven by the integral air compressor.Same
Environment of UseHome, Hospital, Sub-acute InstitutionsSame
Patient PopulationPediatric and adultSame
ContraindicationsNoneSame
Pneumatic compressorYesYes
Pneumatic nebulizerYesYes
Software drivenNoNo
Materials in patientcontactPolypropyleneIdentical
Standard metIEC 60601-1, IEC 60601-1-2, UL 60601-1, FCC Part 15ISO 14971Same
Drug delivery rate0.35 ml/min0.4 ml/min
Reservoir size7 ml7 ml
Nebulizer componentscleanableYesYes
Operating conditions10°C to 40°C 30% to 85% RHSame
Storage conditions-20°C to 60°C 10% to 90% RHSame
Dimensions (mm)168(W) x 175(D) x 100(H)124(W) x 98(D) x51(H)
Weight (kg) withoutbattery1.7 kg0.4 kg

Differences Between Other Legally Marketed Predicate Devices

The Models NE-C28 and NE-C30 are viewed as substantially equivalent to the following predicate device – Omron NE-C09 – K914836.

There are no significant differences that affect the safety or effectiveness of the intended device as compared to the predicate devices.

{2}------------------------------------------------

Image /page/2/Picture/1 description: The image shows the seal of the Department of Health and Human Services (HHS) of the United States. The seal features a stylized eagle with three lines forming its body and wings, symbolizing health, services, and people. The text "DEPARTMENT OF HEALTH AND HUMAN SERVICES . USA" is arranged in a circular pattern around the eagle.

Public Health Service

Food and Drug Administration 9200 Corporate Boulevard Rockville MD 20850

MAY 2 5 2006

Omron Healthcare, Incorporated C/O Mr. Paul Dryden President ProMedic, Incorporated 6329 West Waterview Court Mccordsville, Indiana 46055-9501

Re: K060811

Trade/Device Name: Omron Compressor Systems, Models NE-C28 and NE-C30 Regulation Number: 868.5630 Regulation Name: Nebulizer Regulatory Class: II Product Code: CAF Dated: March 23, 2006 Received: March 24 2006

Dear Mr. Dryden:

We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration.

If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to such additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.

{3}------------------------------------------------

Page 2 - Mr. Dryden

Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.

This letter will allow you to begin marketing your device as described in your Section 510(k) premarket notification. The FDA finding of substantial equivalence of your device to a legally marketed predicate device results in a classification for your device and thus, permits vour device to proceed to the market.

If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please contact the Office of Compliance at (240) 276-0120. Also, please note the regulation entitled. "Misbranding by reference to premarket notification" (21CFR Part 807.97). You may obtain other general information on your responsibilities under the Act from the Division of Small Manufacturers, International and Consumer Assistance at its toll-free number (800) 638-2041 or (301) 443-6597 or at its Internet address http://www.fda.gov/cdrh/industry/support/index.html.

Sincerely yours,

Chiu Lin, Ph.D.

Director Division of Anesthesiology, General Hospital, Infection Control and Dental Devices Office of Device Evaluation Center for Devices and Radiological Health

Enclosure

{4}------------------------------------------------

Premarket Notification 510(k) - Response to e-mail of 5-May-06

Indications for Use Statement

K060811 510(k) Number:

Models NE-C28 and NE-C30 Device Name:

The Omron Compressor Nebulizer Systems include a Indications for Use: compressor and nebulizer, Model NE-C28 uses a DC powered compressor and Model NE-C30 can operate with AC/DC power. The electrically powered compressor provides compressed air to the supplied pneumatic nebulizer to aerosolize drugs for inhalation by the patient.

The nebulizer is driven by the integral air compressor. The device may be used with pediatric and adult patients in the home, hospital, and sub-acute care settings.

It is not intended for use with Pentamidine.

Prescription Use XX (Part 21 CFR 801 Subpart D) or

Over-the-counter use (21 CFR 807 Subpart C)

ﺒﺪﺃ

Omron

(PLEASE DO NOT WRITE BELOW THIS LINE-CONTINUE ON ANOTHER PAGE IF NEEDED)

Concurrence of CDRH, Office of Device Evaluation (ODE)

Auy Sulson

ology, General Hospital,
Contact, Lerial Devices
K060811

§ 868.5630 Nebulizer.

(a)
Identification. A nebulizer is a device intended to spray liquids in aerosol form into gases that are delivered directly to the patient for breathing. Heated, ultrasonic, gas, venturi, and refillable nebulizers are included in this generic type of device.(b)
Classification. Class II (performance standards).